1. Mandibular Distraction in Patients With Pierre Robin Sequence: A Multisurgeon Experience.
- Author
-
Goza SD, Brown MI, Hopper SJ, Phillips J, Sink MC, Brown KW, Fernstrum CJ, Friel MT, Humphries LS, and Hoppe IC
- Subjects
- Humans, Retrospective Studies, Female, Male, Infant, Treatment Outcome, Airway Obstruction surgery, Airway Obstruction etiology, Pierre Robin Syndrome surgery, Pierre Robin Syndrome complications, Osteogenesis, Distraction methods, Mandible surgery
- Abstract
Objective: Mandibular distraction osteogenesis (MDO) is rapidly becoming a standard of care for management of patients with severe Pierre Robin sequence. The tongue is brought forward to alleviate airway obstruction. This study will look at an institutional, multisurgeon experience with MDO over 10 years., Design: A retrospective chart review was conducted., Setting: All patients who underwent MDO at the authors' institution from 2012 to 2022 were included. Three craniofacial surgeons performed all interventions., Patients: Demographics, preoperative and postoperative respiratory and feeding status, and distraction data were collected for 27 patients meeting inclusion criteria., Main Outcome Measures: Primary outcomes were avoidance of a gastrostomy tube, avoidance of a tracheostomy, discharge from hospital on room air, and complications. A significance value of 0.05 was utilized., Results: The average age at MDO was 135 days, mean activation phase was 13.6 days, mean distraction length was 14.9 mm, and mean consolidation phase was 64.2 days. A longer activation phase was associated with discharge with a gastrostomy tube and a shorter activation phase was associated with discharge on full oral feeds. The ability to discharge on room air was associated with a shorter latency phase, shorter activation phase, and decreased distance of distraction., Conclusions: The goal of MDO is to achieve full oral feeds with no respiratory support. Several different latency periods were used in this study, and a short latency period was demonstrated to be safe., Competing Interests: Conflicts of interest and sources of funding: none declared., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF